|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/57 | |
| A61K 31/635 | |||
| A61P 9/02 | |||
| A61P 9/04 |
| (11) | Patento numeris | 1863492 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05814628.3 |
| Europos patento paraiškos padavimo data | 2005-12-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2005/012843 |
| Data | 2005-12-01 |
| (87) | Numeris | WO 2006/058748 |
| Data | 2006-06-08 |
| (30) | Numeris | Data | Šalis |
| 04028474 | 2004-12-01 | EP |
| (72) |
ANKER, Stefan, DE
|
| (73) |
Par Pharmaceuticals, Inc.,
One Ram Ridge Road, Spring Valley, NY 10977,
US
|
| (54) | USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY |
| USE OF MEGESTROL ACETATE FOR IMPROVING HEART FUNCTION AND THE TREATMENT OF HEART INSUFFICIENCY |